MVision’s Guideline-Based AI Segmentation is Available in the EduCase Platform

Helsinki – 19th of January, 2022 – MVision AI, the leading provider of the guideline-based solution, collaborates with EduCase, the global leader in web-based education designed to support contouring skill instructions for radiation oncologists. EduCase is a computer-based training tool developed by RadOnc eLearning Center, LLC., to assist the development of structure segmentation (contouring) skills of radiation oncologists, medical physicists, and dosimetrists. 

The educational collaboration entitles EduCase to include MVision’s guideline-compliant AI segmentation, GCAIS™, software in all teaching sessions. This supplements students with hands-on experience working with MVision’s state-of-the-art solution. The MVisionaries will support EduCase to help educate the students, providing them with the unique opportunity to work with our groundbreaking AI models. 

“We are excited to be working with and delivering this new EdTech feature by integrating MVision’s AI segmentation guideline structures into the EduCase contour training platform. We are seeing significant demand in AI training in radiotherapy, and its impact and influence on the  educational ecosystem of Radiation Oncology, Contouring, and Education.” said Scott Kaylor: Co-Founder of EduCase

“Advancements of AI in Radiotherapy are redefining the role of clinicians. Education and training are becoming essential for clinicians to deliver high-quality treatment. Through our collaboration with EduCase, MVision is very excited to bring AI models to the EduCase platform to further accelerate the adoption of this novel technology” said Mahmudul Hasan: Co-Founder and CEO of MVision AI 

Discover EduCase

Website: https://www.educase.com/ 

LinkedIn: https://www.linkedin.com/company/radonc-elearning-center-inc./ 

Are you eager to explore GCAIS™? Request a demo here. 

MVision AI is active on LinkedIn, Twitter, Facebook, and Instagram. Follow us on social media and subscribe to our newsletter to stay up-to-date on the latest MVision AI news.

Welcome you to contact MVision AI:

c/o Terkko Health Hub, Haartmaninkatu 4, 00290 Helsinki, Finland.

Tel: +358 (0) 40 5489 229

Website: https://www.mvision.ai 

Email: info@mvision.ai 

For media inquiries:

Tel: +358 40 500 7915

Email: pr@mvision.ai

Our Newsletter

Subscribe to get information, latest news and other interesting offers about MVision AI

Related Posts

26.8.2024

Lung Cancer Awareness–Examining Tobacco’s Effect

As August comes to a close, we take a moment to reflect on World Lung Cancer Day, observed earlier this month. This year’s focus has underscored the critical fact that tobacco smoking remains the leading cause of lung cancer. Understanding this connection is essential for both prevention and treatment, emphasizing…

News

6.8.2024

MVision AI Secures CDSCO Approval to Revolutionize Cancer Treatment Planning in India

HELSINKI, Finland – August, 2024 MVision AI is excited to announce that our application for MVision AI Segmentation (Contour+) has been approved by the Central Drugs Standard Control Organization (CDSCO) under the “Image Segmentation Application Software” category. This approval facilitates the deployment of our advanced image analysis algorithms in radiation…

Press Releases

2.7.2024

Breaking New Ground: MVision AI Contour+ for Upright MRI Scans

Results on testing MVision AI Contour+ for an ingenious and modern approach in radiation therapy have been recently presented at the 62nd Particle Therapy Co-Operative Group (PTCOG) conference in Singapore. Despite being trained using supine MR data and a different magnetic strength from different scanners, authors reported that MVision AI's…

Articles